Vp Of Marketing
CurrentCurrently crowdfunding from private investors on Wefunder: www.wefunder.com/osnovumWe are pioneering a precision approach to develop regenerative therapies designed to transform the lives of patients with osteoporotic conditions. Our technology has been FDA-cleared and on the market for years regenerating maxillofacial bone thanks to decades of vigorous research and development offered by our founders through SteinerBio.OsNovum is now taking this regenerative material, which converts poorly mineralized bone into dense, healthy tissue, to the skeleton through a local application into an areas of weakened bone.